Statement: in order to qualify for the primary clinical trial, patients must have a diagnosis of hormone receptor-positive advanced breast cancer, without having undergone any prior treatment for this advanced condition
Primary_evidence: Inclusion Criteria:   Confirmed hormone receptor positive advanced breast cancer, postmenopausal women Exclusion Criteria:   Previous treatment for advanced breast cancer (previous treatment for early breast cancer is allowed).